Skip to main content
. 2022 Oct 28;9:981984. doi: 10.3389/fnut.2022.981984

Figure 12.

Figure 12

The findings of this study at a quick glance. AFs in production/storage sites caused damage to target products and passed to consumers, leading to the progression of nCDs (Steps 1–5). Certain classes of PPs alleviated the side effects of AFs by modulating several critical signaling pathways involved in the pathogenesis of AFs. Indeed, these compounds could inhibit the formation of AFs by regulating expression of critical genes involved in biosynthetic pathways of AFs (Steps 6–8). Climate change markedly affects the occurrence of AFs, therefore, developing PPs-rich GM plants might be considered as a strategic policy to decrease the quantity of these mycotoxins. GMCs, genetically modified crops; PKD, Parkinson's disease; EP, epilepsy; IBD, inflammatory bowel disease; CD, cardiovascular diseases; KD, kidney diseases; LD, liver diseases; HP, hemophilia; SD, seizure disorder; CF, cystic fibrosis.